2 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow lenacapavir: new trials by email Literature Review of lenacapavir trials Research Report on lenacapavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy Lenacapavir - Human Immunodeficiency Virus | Phase 1 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 50 | 2026-01-20 | 2026-10-15 |
| Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab - HIV-1 Infection | Phase 1 | Completed | Gilead Sciences | 32 | 2021-04-08 | 2025-01-27 |
| Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults Lenacapavir, Placebo, B/F/TAF - HIV-1 Infection | Phase 1 | Completed | Gilead Sciences | 53 | 2018-11-26 | 2021-04-09 |
Acquired Immunodeficiency Syndrome (1)
Gilead Sciences (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (3)